216 related articles for article (PubMed ID: 38531951)
1. Interrogation of the human cortical peptidome uncovers cell-type specific signatures of cognitive resilience against Alzheimer's disease.
Morgan GR; Carlyle BC
Sci Rep; 2024 Mar; 14(1):7161. PubMed ID: 38531951
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid and Brain Proteoforms of the Granin Neuropeptide Family in Alzheimer's Disease.
Quinn JP; Ethier EC; Novielli A; Malone A; Ramirez CE; Salloum L; Trombetta BA; Kivisäkk P; Bremang M; Selzer S; Fournier M; Das S; Xing Y; Arnold SE; Carlyle BC
J Am Soc Mass Spectrom; 2023 Apr; 34(4):649-667. PubMed ID: 36912488
[TBL] [Abstract][Full Text] [Related]
3. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics.
Carlyle BC; Kandigian SE; Kreuzer J; Das S; Trombetta BA; Kuo Y; Bennett DA; Schneider JA; Petyuk VA; Kitchen RR; Morris R; Nairn AC; Hyman BT; Haas W; Arnold SE
Neurobiol Aging; 2021 Sep; 105():99-114. PubMed ID: 34052751
[TBL] [Abstract][Full Text] [Related]
4. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
5. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.
Aiello Bowles EJ; Crane PK; Walker RL; Chubak J; LaCroix AZ; Anderson ML; Rosenberg D; Keene CD; Larson EB
J Alzheimers Dis; 2019; 68(3):1071-1083. PubMed ID: 30909217
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies.
Arenaza-Urquijo EM; Przybelski SA; Lesnick TL; Graff-Radford J; Machulda MM; Knopman DS; Schwarz CG; Lowe VJ; Mielke MM; Petersen RC; Jack CR; Vemuri P
Brain; 2019 Apr; 142(4):1134-1147. PubMed ID: 30851100
[TBL] [Abstract][Full Text] [Related]
9. Application of deep learning to understand resilience to Alzheimer's disease pathology.
Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY
Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663
[TBL] [Abstract][Full Text] [Related]
10. Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.
Perez SE; He B; Nadeem M; Wuu J; Scheff SW; Abrahamson EE; Ikonomovic MD; Mufson EJ
Biol Psychiatry; 2015 Apr; 77(8):693-703. PubMed ID: 24529280
[TBL] [Abstract][Full Text] [Related]
11. Neurogranin in Alzheimer's disease and ageing: A human post-mortem study.
Saunders T; Gunn C; Blennow K; Kvartsberg H; Zetterberg H; Shenkin SD; Cox SR; Deary IJ; Smith C; King D; Spires-Jones T
Neurobiol Dis; 2023 Feb; 177():105991. PubMed ID: 36623608
[TBL] [Abstract][Full Text] [Related]
12. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
[TBL] [Abstract][Full Text] [Related]
13. Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes.
Gómez-Isla T; Frosch MP
Nat Rev Neurol; 2022 Jun; 18(6):323-332. PubMed ID: 35332316
[TBL] [Abstract][Full Text] [Related]
14. Integrated Proteomics to Understand the Role of Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer's Disease.
Hurst C; Pugh DA; Abreha MH; Duong DM; Dammer EB; Bennett DA; Herskowitz JH; Seyfried NT
Mol Cell Proteomics; 2023 May; 22(5):100542. PubMed ID: 37024090
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
16. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
[TBL] [Abstract][Full Text] [Related]
17. Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer's Disease.
Consens ME; Chen Y; Menon V; Wang Y; Schneider JA; De Jager PL; Bennett DA; Tripathy SJ; Felsky D
Front Mol Neurosci; 2022; 15():903175. PubMed ID: 35754708
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain.
Podvin S; Jiang Z; Boyarko B; Rossitto LA; O'Donoghue A; Rissman RA; Hook V
ACS Chem Neurosci; 2022 Jul; 13(13):1992-2005. PubMed ID: 35758417
[TBL] [Abstract][Full Text] [Related]
19. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
Negash S; Xie S; Davatzikos C; Clark CM; Trojanowski JQ; Shaw LM; Wolk DA; Arnold SE
Alzheimers Dement; 2013 May; 9(3):e89-95. PubMed ID: 23127468
[TBL] [Abstract][Full Text] [Related]
20. The concept of resilience to Alzheimer's Disease: current definitions and cellular and molecular mechanisms.
de Vries LE; Huitinga I; Kessels HW; Swaab DF; Verhaagen J
Mol Neurodegener; 2024 Apr; 19(1):33. PubMed ID: 38589893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
